Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.53 |
| ▸ | PBK | Q96KB5 | 5/20 | 0.51 |
| ▸ | GRM5 | P41594 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CDK2AP1 | O14519 | 2/20 | 0.47 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | ANPEP | P15144 | 1/20 | 0.45 |
| ▸ | KDM5A | P29375 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3460359 | 1.00 | SMYD3 (0.53) | SMYD3PBKGRM5GAAMAPT | |
| SCHEMBL3462774 | 1.00 | SMYD3 (0.53) | SMYD3PBKGRM5GAAMAPT | |
| SCHEMBL3460000 | 0.92 | SMYD3 (0.55) | SMYD3PBKGRM5GAAMAPT | |
| SCHEMBL3462385 | 0.92 | SMYD3 (0.55) | SMYD3PBKGRM5GAAMAPT | |
| SCHEMBL28266316 | 0.84 | SMYD3 (0.66) | SMYD3GRM5GAAMAPTALDH1A1 | |
| SCHEMBL12218526 | 0.83 | GAA (0.64) | SMYD3GRM5GAAMAPTALDH1A1 | |
| SCHEMBL20451349 | 0.83 | GAA (0.64) | SMYD3GRM5GAAMAPTALDH1A1 | |
| SCHEMBL31227157 | 0.81 | GRM5 (0.68) | SMYD3PBKGRM5GAACDK2AP1 | |
| SCHEMBL1535206 | 0.81 | SMYD3 (0.74) | SMYD3GRM5GAAMAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL16528325 | 0.80 | GRM5 (0.67) | SMYD3PBKGRM5GAACHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7704995-B2 | Protein kinase modulators and methods of use | EXELIXIS, INC. (US) | 2010-04-27 | — | — | US | disclosed |
| US-20060211709-A1 | Protein kinase modulators and methods of use | EXELIXIS, INC. | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211709-A1 | Protein kinase modulators and methods of use | GRK2, MAP4K2, MAPKAPK2 | SMYD3 3540/4885PBK 3421/4885GRM5 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.